William Blair downgrades MRNA from Outperform to Market PerformWilliam Blair 把 莫德纳 (MRNA) 评级 下调:跑赢大市(Outperform) → 与大市持平(Market Perform)
On 2026-10-27, William Blair downgraded MRNA to Market Perform from Outperform.
William Blair 于 2026-10-27 将 MRNA 评级下调至 与大市持平(Market Perform),此前为 跑赢大市(Outperform)。
For information only. Not investment advice.内容仅供参考,不构成投资建议。